151 related articles for article (PubMed ID: 22971053)
1. How effective is effective enough? Opinions of potential end-users of microbicides from a rural South African community.
Gafos M; Mzimela MA; Ndlovu HB; McCormack S; McGrath N
AIDS Care; 2013; 25(5):573-8. PubMed ID: 22971053
[TBL] [Abstract][Full Text] [Related]
2. Communicating about microbicides with women in mind: tailoring messages for specific audiences.
Sidibe S; Pack AP; Tolley EE; Ryan E; Mackenzie C; Bockh E; Githuka G
J Int AIDS Soc; 2014; 17(3 Suppl 2):19151. PubMed ID: 25224612
[TBL] [Abstract][Full Text] [Related]
3. Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction.
Lanham M; Wilcher R; Montgomery ET; Pool R; Schuler S; Lenzi R; Friedland B
J Int AIDS Soc; 2014; 17(3 Suppl 2):19159. PubMed ID: 25224618
[TBL] [Abstract][Full Text] [Related]
4. Microbicides and HIV: help or hindrance?
Karmon E; Potts M; Getz WM
J Acquir Immune Defic Syndr; 2003 Sep; 34(1):71-5. PubMed ID: 14501797
[TBL] [Abstract][Full Text] [Related]
5. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L
J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845
[TBL] [Abstract][Full Text] [Related]
6. Shifts in condom use following microbicide introduction: should we be concerned?
Foss AM; Vickerman PT; Heise L; Watts CH
AIDS; 2003 May; 17(8):1227-37. PubMed ID: 12819525
[TBL] [Abstract][Full Text] [Related]
7. Communication About Microbicide Use Between Couples in KwaZulu-Natal, South Africa.
Gafos M; Pool R; Mzimela MA; Ndlovu HB; McCormack S; Elford J;
AIDS Behav; 2015 May; 19(5):832-46. PubMed ID: 25488170
[TBL] [Abstract][Full Text] [Related]
8. Perceptions of acceptability and utility of microbicides in Ghana, West Africa: a qualitative, exploratory study.
Tanner AE
SAHARA J; 2008 Apr; 5(1):11-8. PubMed ID: 18496615
[TBL] [Abstract][Full Text] [Related]
9. Blockage and flow: intimate experiences of condoms and microbicides in a South African clinical trial.
Stadler J; Saethre E
Cult Health Sex; 2011 Jan; 13(1):31-44. PubMed ID: 20960355
[TBL] [Abstract][Full Text] [Related]
10. An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana.
Abdulai MA; Baiden F; Adjei G; Afari-Asiedu S; Adjei K; Tawiah C; Newton S
BMC Womens Health; 2012 Nov; 12():40. PubMed ID: 23114222
[TBL] [Abstract][Full Text] [Related]
11. The implications of post-coital intravaginal cleansing for the introduction of vaginal microbicides in South Africa.
Gafos M; Pool R; Mzimela MA; Ndlovu HB; McCormack S; Elford J;
AIDS Behav; 2014 Feb; 18(2):297-310. PubMed ID: 24337726
[TBL] [Abstract][Full Text] [Related]
12. Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptake.
Govender EM; Mansoor LE; Abdool Karim Q
AIDS Care; 2017 Jun; 29(6):734-740. PubMed ID: 27799005
[TBL] [Abstract][Full Text] [Related]
13. Topical microbicides for prevention of sexually transmitted infections.
Obiero J; Mwethera PG; Wiysonge CS
Cochrane Database Syst Rev; 2012 Jun; (6):CD007961. PubMed ID: 22696373
[TBL] [Abstract][Full Text] [Related]
14. "One teabag is better than four": Participants response to the discontinuation of 2% PRO2000/5 microbicide gel in KwaZulu-Natal, South Africa.
Gafos M; Mzimela M; Ndlovu H; Mhlongo N; Hoogland Y; Mutemwa R
PLoS One; 2011 Jan; 6(1):e14577. PubMed ID: 21344002
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the potential impact of vaginal microbicides to reduce the risk of acquiring HIV in female sex workers.
Smith RJ; Bodine EN; Wilson DP; Blower SM
AIDS; 2005 Mar; 19(4):413-21. PubMed ID: 15750395
[TBL] [Abstract][Full Text] [Related]
16. Learning from the private sector: towards a keener understanding of the end-user for microbicide introduction planning.
Lin AH; Breger TL; Barnhart M; Kim A; Vangsgaard C; Harris E
J Int AIDS Soc; 2014; 17(3 Suppl 2):19162. PubMed ID: 25224619
[TBL] [Abstract][Full Text] [Related]
17. 'Why would you promote something that is less percent safer than a condom?': Perspectives on partially effective HIV prevention technologies among key populations in South Africa.
Rubincam C; Newman PA; Atujuna M; Bekker LG
SAHARA J; 2018 Dec; 15(1):179-186. PubMed ID: 30360675
[TBL] [Abstract][Full Text] [Related]
18. Gender relations in the context of HIV/AIDS in rural South Africa.
Ndinda C; Uzodike UO; Chimbwete C; Pool R;
AIDS Care; 2007 Aug; 19(7):844-9. PubMed ID: 17712686
[TBL] [Abstract][Full Text] [Related]
19. Willingness of clinicians to integrate microbicides into HIV prevention practices in southern Africa.
Harper CC; Holt K; Nhemachena T; Chipato T; Ramjee G; Stratton L; Blum M; McCulloch CE; Mgweba S; Blanchard K
AIDS Behav; 2012 Oct; 16(7):1821-9. PubMed ID: 22210482
[TBL] [Abstract][Full Text] [Related]
20. The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.
Morrow K; Rosen R; Richter L; Emans A; Forbes A; Day J; Morar N; Maslankowski L; Profy AT; Kelly C; Abdool Karim SS; Mayer KH
J Womens Health (Larchmt); 2003 Sep; 12(7):655-66. PubMed ID: 14583106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
